Chemical Structure (Sirolimus 01)
Sirolimus Tablet, Sugar Coated
Product Images NDC 59762-1002
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sirolimus (NDC 59762-1002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Sirolimus 02)
This appears to be a table of data related to a clinical trial's treatment phase. The columns appear to include a duration of 16 months, with dosages of a drug called Siroimus being administered to a total of 46 subjects over the course of the trial. However, the output is incomplete and contains several errors, making it difficult to determine the full context and meaning of the data presented.*
Logo (Sirolimus 03)
This is a description of the GREENSTONE® brand, which is distributed by Greenstone LLC from Peapack, NJ 07977.*
Logo (Sirolimus 04)
This is a description of a greenstone brand that is distributed by Greenstone LLC based in Peapack, NJ 07977.*
Principal Display Panel (0.5 mg Tablet Bottle Label)
This is a medication guide for the Greenstone brand Sirolimus tablets. The medication should be stored at room temperature, between 20 and 25°C, in a tight light-resistant container. The dosage and usage information is not provided and should be obtained from the accompanying prescribing information. The product is distributed in the US by Greenstone LLC and is made in Japan. The NDC number for this product is 59762-1001-1 with a package size of 100 tablets.*
Principal Display Panel (1 mg Tablet Bottle Label)
Store the medication at room temperature, between 20°C to 25°C (68°F to 77°F), in a USP defined tight light resistant container. Dosage and usage are available in the prescribing information. The product is manufactured in Japan and distributed by Greenstone LLC in Peapack, NJ. The product is identified by the NDC number 59762-1002-1 and the medication is Sirolimus in tablet form.*
Principal Display Panel (2 mg Tablet Bottle Label)
Store the product in a light-resistant container at room temperature between 20°C to 25°C (68°F to 77°F) according to the USP guidelines. The product is distributed by Greenstone LLC and made in Japan. For dosage and usage information, refer to the accompanying prescribing information. The medication guide has 100 tablets of Greenstone brand sirolimus which is identified as NDC 59762-1003-1 with code PAAD63675.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
